SIRT6 and breast cancer: In addition, SIRT6 stimulated the invasiveness of cancer cells by activating the epithelial-to-mesenchymal transition pathway in breast cancer, ovarian cancer, lung cancer, and osteosarcoma cells [14, 16, 35, 42].